This announcement is a separate document:
百诚医药:关于2022年限制性股票激励计划首次及预留部分第二个归属期归属结果暨股份上市的公告
Baicheng Pharmaceutical: Announcement on the results of the ownership of the 2022 Restricted Stock Incentive Plan for the first and second reserved period and share listing
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.